🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- IPO
- 10/9/2026 · $14/share
Business: TRex Bio, Inc is a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines. The Company’s Deep Biology platform decodes Treg functionality in human tissue, mapping key drivers of immune dysregulation and uncovering novel targets and insights that inform drug discovery and translational efforts.
Company Contact
- CEO
- M. Johnston Erwin, Jr.
- CFO
- Brandon Hants
- Headquarters
- 269 East Grand Avenue, Suite 300, South San Francisco, CA 94080
- Phone
- 650-567-5582
- Investor Relations
- IR@trex.bio